Lumen Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.01 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.01 Cr
as on 17-11-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.24 Cr
as on 17-11-2024
- Revenue 23.91%
(FY 2023)
- Profit 23.69%
(FY 2023)
- Ebitda 17.71%
(FY 2023)
- Net Worth 86.73%
(FY 2023)
- Total Assets 3.81%
(FY 2023)
About Lumen Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 1.01 Cr.
The company currently has active open charges totaling ₹4.24 Cr.
Bhavanaben Patel, Kanchanben Patel, Dashrathbhai Patel, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2015PTC083118
- Company No.
083118
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Lumen Pharmachem Private Limited offer?
Lumen Pharmachem Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Flavours & Aromatics, Food Grade Chemical, Digestive System Drugs & Medicines, Antacid Drugs, Bakery & Confectionery Flavors, Dyes & Color Additives, Pigment Extenders, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Lumen Pharmachem?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavanaben Patel  | Director | 05-May-2015 | Current |
| Kanchanben Patel | Director | 05-May-2015 | Current |
| Dashrathbhai Patel | Director | 05-May-2015 | Current |
| Shashikant Patel | Director | 05-May-2015 | Current |
| Pratikkumar Patel | Director | 07-Feb-2017 | Current |
| Tirth Patel | Director | 07-Feb-2017 | Current |
Financial Performance of Lumen Pharmachem.
Lumen Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.91% increase. The company also saw a substantial improvement in profitability, with a 23.69% increase in profit. The company's net worth Soared by an impressive increase of 86.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lumen Pharmachem?
In 2023, Lumen Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Velivadi Resort Private LimitedActive 4 years 22 days
Tirth Patel and Sarojben Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 May 2023 | ₹0.50 M | Open |
Others Creation Date: 16 Feb 2022 | ₹2.20 M | Open |
Others Creation Date: 16 Oct 2020 | ₹4.70 M | Open |
How Many Employees Work at Lumen Pharmachem?
Unlock and access historical data on people associated with Lumen Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lumen Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lumen Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
